Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life

@article{Thomsen2002BudesonideAM,
  title={Budesonide and mesalazine in active Crohn's disease: a comparison of the effects on quality of life},
  author={Ole \Ostergaard Thomsen and Antoine Cortot and Derek Jewell and John Philip Wright and Trevor Winter and Fernando Tavarela Veloso and Morten Harald Vatn and Tore Persson and Eva Pettersson},
  journal={American Journal of Gastroenterology},
  year={2002},
  volume={97},
  pages={649-653}
}
OBJECTIVES:Controlled ileal release budesonide and slow release mesalazine are both used to treat mild to moderate active Crohn's disease, although data show that budesonide is more effective in inducing remission. When comparing different treatment options, the effects of agents on health-related quality of life must be considered as well as efficacy. In this study, we sought to compare the effects of budesonide and mesalazine on the health-related quality of life of patients with active Crohn… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 17 references

The effect of hypo

SJ Jachuck, H Brierley, S Jachuck
Thomsen et al. AJG – Vol. 97, • 2002
View 1 Excerpt

Controlled-release budesonide in Crohn's disease.

Drug and therapeutics bulletin • 1997

Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn’s disease

JW Singleton, S Hanauer, M. Robinson
Dig Dis Sci • 1995
View 1 Excerpt

Similar Papers

Loading similar papers…